Tumor markers SCCAg and CYFRA 21.1, cytokines IL-6 and VEGF, and soluble tumor necrosis factor receptors sTNFR I and II were evaluated as possible prognostic factors in all patients in the early stages of cancer development with a similar prognosis. This evidence concerns the gene IL6 and neoplasm.